Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
bristol-myers squibb
cancer immunotherapy
deals
johnson & johnson
startups
abbvie
aducanumab
affordable care act
alzheimer's disease
avexis
bayer
What
nash
4
×
news
4
×
roundup
4
×
bio
drug
biogen’s
companies
disease
according
aducanumab
akcea
alzheimer’s
amyloid
angst
approval
approved
bagged
billions
biogen
biopharmaceutical
biotech
brammer
cases
centers
cigarettes
control
convo
deaths
digital
earlier
effects
electronic
epidemic
failure
failures
fatty
fda
felt
frenzied
growing
Language
unset
Current search:
nash
×
roundup
×
news
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More